BRM
LH icon

Boston Research & Management’s Labcorp LH Stock Holding History

Boston Research & Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.22M Sell
23,308
-235
-1% -$63.6K 1.48% 28
2025
Q4 		$5.91M Sell
23,543
-598
-2% -$159K 1.36% 29
2025
Q3 		$6.93M Sell
24,141
-20
-0.1% -$5.36K 1.53% 24
2025
Q2 		$6.34M Sell
24,161
-204
-0.8% -$49.7K 1.52% 22
2025
Q1 		$5.67M Sell
24,365
-972
-4% -$236K 1.41% 27
2024
Q4 		$5.81M Buy
25,337
+128
+0.5% +$29.4K 1.43% 25
2024
Q3 		$5.63M Buy
25,209
+525
+2% +$115K 1.32% 33
2024
Q2 		$5.02M Buy
24,684
+217
+0.9% +$44.1K 1.27% 33
2024
Q1 		$5.34M Buy
24,467
+338
+1% +$74.5K 1.32% 34
2023
Q4 		$5.48M Buy
24,129
+1,151
+5% +$242K 1.46% 26
2023
Q3 		$4.62M Sell
22,978
-3,108
-12% -$656K 1.37% 27
2023
Q2 		$5.41M Sell
26,086
-31
-0.1% -$6.01K 1.53% 22
2023
Q1 		$5.15M Buy
26,117
+332
+1% +$68.3K 1.54% 22
2022
Q4 		$5.22M Sell
25,785
-163
-0.6% -$31.9K 1.61% 21
2022
Q3 		$4.57M Buy
25,948
+505
+2% +$103K 1.56% 24
2022
Q2 		$5.12M Buy
25,443
+678
+3% +$145K 1.66% 20
2022
Q1 		$5.61M Sell
24,765
-497
-2% -$117K 1.63% 18
2021
Q4 		$6.82M Sell
25,262
-123
-0.5% -$30.4K 1.86% 18
2021
Q3 		$6.14M Sell
25,385
-369
-1% -$93K 1.83% 18
2021
Q2 		$6.1M Sell
25,754
-88
-0.3% -$20.1K 1.85% 19
2021
Q1 		$5.66M Sell
25,842
-364
-1% -$73K 1.82% 20
2020
Q4 		$4.58M Buy
26,206
+266
+1% +$45.9K 1.59% 27
2020
Q3 		$4.2M Sell
25,940
-1,051
-4% -$167K 1.64% 27
2020
Q2 		$3.85M Sell
26,991
-8
-0% -$1.11K 1.6% 28
2020
Q1 		$2.93M Sell
26,999
-863
-3% -$124K 1.47% 33
2019
Q4 		$4.05M Buy
27,862
+222
+0.8% +$32.1K 1.52% 34
2019
Q3 		$3.99M Buy
27,640
+838
+3% +$122K 1.58% 35
2019
Q2 		$3.98M Sell
26,802
-88
-0.3% -$12.3K 1.61% 31
2019
Q1 		$3.53M Buy
26,890
+1,828
+7% +$225K 1.47% 34
2018
Q4 		$2.72M Sell
25,062
-384
-2% -$51.4K 1.3% 40
2018
Q3 		$3.8M Buy
25,446
+116
+0.5% +$17.6K 1.73% 26
2018
Q2 		$3.91M Sell
25,330
-756
-3% -$114K 1.92% 14
2018
Q1 		$3.62M Sell
26,086
-35
-0.1% -$5.14K 1.85% 20
2017
Q4 		$3.58M Sell
26,121
-908
-3% -$120K 1.79% 22
2017
Q3 		$3.5M Sell
27,029
-29
-0.1% -$3.87K 1.79% 21
2017
Q2 		$3.58M Buy
27,058
+163
+0.6% +$20K 1.94% 17
2017
Q1 		$3.31M Sell
26,895
-460
-2% -$54.5K 1.81% 21
2016
Q4 		$3.02M Buy
27,355
+396
+1% +$44K 1.72% 27
2016
Q3 		$3.18M Sell
26,959
-745
-3% -$87.8K 1.84% 19
2016
Q2 		$3.1M Sell
27,704
-489
-2% -$52.6K 1.88% 18
2016
Q1 		$2.84M Buy
28,193
+35
+0.1% +$3.36K 1.77% 23
2015
Q4 		$2.99M Buy
28,158
+308
+1% +$31.8K 1.86% 17
2015
Q3 		$2.6M Sell
27,850
-180
-0.6% -$18.6K 1.71% 23
2015
Q2 		$2.92M Buy
28,030
+192
+0.7% +$20K 1.85% 20
2015
Q1 		$3.02M Sell
27,838
-1,147
-4% -$118K 1.91% 19
2014
Q4 		$2.69M Buy
28,985
+1,123
+4% +$99.2K 1.68% 22
2014
Q3 		$2.44M Buy
27,862
+437
+2% +$39.5K 1.64% 25
2014
Q2 		$2.41M Buy
27,425
+204
+0.7% +$17.7K 1.67% 21
2014
Q1 		$2.3M Buy
27,221
+489
+2% +$39K 1.69% 21
2013
Q4 		$2.1M Buy
26,732
+2,259
+9% +$193K 1.61% 29
2013
Q3 		$2.08M Buy
24,473
+198
+0.8% +$16.7K 1.76% 23
2013
Q2 		$2.09M Buy
+24,275
New +$2.02M 1.86% 20

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Research & Management's LH Position: Q1 2026 in Review

Boston Research & Management reduced its Labcorp (LH) stake by 1% in Q1 2026, selling an estimated $63.6K and leaving 23,308 shares worth $6.22M. The position accounts for 1.48% of the portfolio, ranked #28.

Boston Research & Management first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.93M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Boston Research & Management held 23,308 shares of Labcorp worth $6.22M as of Q1 2026.
  • Boston Research & Management sold 235 Labcorp shares in Q1 2026, an estimated $63.6K.
  • Labcorp made up 1.48% of Boston Research & Management's portfolio in Q1 2026, its #28 holding.
  • Boston Research & Management first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Labcorp position peaked at $6.93M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.